Chlordiazepoxide/clidinium bromide is indicated to control emotional and somatic factors in gastrointestinal disorders.10 It may also be used as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.11
Donnelly P (2010). "Gasterointestinal Drugs". Nurse's Handbook of Combination Drugs (2nd ed.). Sudbury, Mass.: Jones and Bartlett Publishers. p. 537. ISBN 978-0-7637-6549-1. 978-0-7637-6549-1 ↩
"Librax". MedlinePlus: US National library of medicine. Retrieved 31 May 2013. https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601036.html ↩
"Chlordiazepoxide". MedScape. https://reference.medscape.com/drug/librax-chlordiazepoxide-clidinium-999569 ↩
"Clidinium". Drugs.com. https://www.drugs.com/monograph/clidinium.html ↩
"Librax: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 15 August 2020. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012750 ↩
"Librax- chlordiazepoxide hydrochloride and clidinium bromide capsule". DailyMed. 31 May 2020. Retrieved 15 August 2020. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f99ebf66-f207-4a97-9666-4da1d72b061c ↩
"Chlordiazepoxide hydrochloride and clidinium bromide: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 15 August 2020. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211421 ↩